The total output value of the pharmaceutical industry is still growing fast, facing better development opportunities

[market analysis of China Pharmaceutical network] although the growth rate of the total output value of the pharmaceutical industry has slowed down in recent two years, with the continuous promotion of the reform of the medical system, the expenditure of medical and health care has increased year by year, and the pharmaceutical industry in China has maintained a rapid growth rate In general, the pharmaceutical industry in the 13th Five Year Plan period is facing better development opportunities But we should also see that developed countries are forming new competitive advantages relying on technological change and technological breakthrough, and other emerging market countries have won the first chance in the international competition of generic drugs Since 2001, the total output value of China's pharmaceutical industry has maintained rapid growth, and China has become a large emerging pharmaceutical market in the world According to the prospective database statistics, the compound growth rate of the total output value of China's seven categories of pharmaceutical industry during the 11th Five Year Plan period reached 23.32% Since the 12th Five Year Plan, the total output value of the pharmaceutical industry has maintained a rapid growth trend, but the growth rate has slowed down due to multiple factors such as economic restructuring According to the data of the market outlook and investment analysis report of the pharmaceutical industry released by the prospective industry research institute, the total output value of the pharmaceutical industry in 2013-2015 increased by 18.79%, 15.70% and 12.56% year on year respectively In 2016, the total output value of China's pharmaceutical industry will reach 3239.5 billion yuan, an increase of 11.56% year on year Source: Although the growth rate of the total output value of the pharmaceutical industry has slowed down in the past two years, with the continuous promotion of the reform of the medical system, the medical and health expenditure has increased year by year, and the pharmaceutical industry in China has maintained a rapid growth rate In 2016, the sales revenue of the pharmaceutical industry picked up compared with 2015 In 2016, the sales revenue of the pharmaceutical industry was 2946.3 billion yuan, and it is expected that in 2017, the sales revenue of the pharmaceutical industry in China will reach 3265.1 billion yuan Analysis on the trend of sales revenue of China's pharmaceutical industry source: from a global perspective, the growth rate of pharmaceutical market in developed economies has picked up, the demand of emerging pharmaceutical market is strong, and the proportion of biotechnological drugs and chemical generic drugs in the drug structure has increased, bringing new opportunities for China's pharmaceutical export At home, the national economy has maintained a medium to high growth rate, the disposable income of residents has increased and the consumption structure has been upgraded, the construction of a healthy China has been steadily promoted, the health insurance system has been further improved, the aging population and the implementation of the comprehensive two child policy will continue to promote the rapid growth of the pharmaceutical market In general, the pharmaceutical industry in the 13th Five Year Plan period is facing better development opportunities However, we should also see that developed countries are forming new competitive advantages relying on technological change and technological breakthrough, and other emerging market countries have won the first chance in the international competition of generic drugs; In the early stage, the driving force supporting the rapid growth of China's pharmaceutical industry is weakening, various constraints are continuously strengthened, structural contradictions are further highlighted, it is urgent to accelerate the transformation of growth momentum from the old to the new, and the sustainable and healthy development of the pharmaceutical industry still faces many difficulties and challenges Original title: high growth of output value of pharmaceutical industry